You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1274629 |
---|---|
Category | Antibodies |
Description | SARS-CoV-2 Spike RBD Antibody [2165] |
Clonality | Recombinant |
Clone Number | 2165 |
Tested applications | ELISA, IHC, NeA |
Reactivity | Virus |
Isotype | Human IgG1 |
Immunogen | Sequenced from human survivors of COVID-19 (SARS-CoV-2). These are made recombinantly in HEK293 cells. The spike RBD is expressed on the surface of SARS-CoV-2. |
Concentration | ≥ 1.0 mg/ml |
Form/Appearance | Liquid |
Conjugation | Unconjugated |
Storage | Functional grade preclinical antibodies may be stored sterile as received at 2-8˚ C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80˚ C. Avoid Repeated Freeze Thaw Cycles. |
Buffer/Preservatives | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added. |
Alternative names | SARS-CoV-2 Spike RBD Antibody, Receptor Binding Do Read more... |
Note | For research use only |
Application notes | ELISA (Quality Tested by BIorbyt); N, IHC (Other applications as reported in literature) |
Expiration Date | 12 months from date of receipt. |
SARS-CoV-2 Spike RBD Antibody (clone 2165) IHC Data using infected cell pellets.
Coating: Purified Recombinant SARS-CoV-2 Spike RBD, concentration of 1 ul/well, 100 ul/well overnight 2-8 ˚C. Detection: Anti-SARS-CoV-2 RBD (Clone 2165) conjugated to HRP was serially diluted starting at 25 ng/ml down to 0.23 ng/ml, 100 ul/well for 1 hour at 37 ˚C. Substrate: TMB, 100 ul/well for 15 min, at room temperature followed by 450 nm stop solution, 50ul/well.
Anti-SARS-CoV-2 Antibody to the Recepter Binding Domain (RBD) (Clone 2165). Antibody binds to RBD and blocks binding to the ACE2 receptor on coated plates using COVID-19 ImmunoRank Neurilization MICRO-ELISA Assay.
Filter by Rating